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Background: Anaplasmosis, caused by Anaplasma phagocytophilum and Anaplasma platys, and ehrlichiosis, caused
by Ehrlichia chaffeensis, Ehrlichia ewingii, the "Panola Mountain Ehrlichia" and Ehrlichia muris-like pathogens have
been identified as emerging tick borne infectious diseases in dogs and human patients. Persistent intravascular
infection with these bacteria is well documented in dogs, but is less well documented in human beings.
Methods: Serology and PCR targeting multiple microbial genes, followed by DNA sequencing, was used to test
sequential blood samples. Tissue culture isolation was attempted in two laboratories.
Results: A. platys, E. chaffeensis, and E. ewingii DNA was amplified from two Anaplasma and Ehrlichia seronegative
family members and their dog, all lacking typical symptoms of anaplasmosis or ehrlichiosis. Following treatment
with doxycycline, the dog and mother were Anaplasma and Ehrlichia spp. PCR negative.
Conclusions: Sequential PCR testing provided molecular evidence supporting intravascular persistence of A. platys
and Ehrlichia spp. in two humans and their dog. Diagnosticians and clinicians should consider the potential for
co-infections due to these tick borne organisms.
Keywords: Anaplasma, Ehrlichia, Rickettsemia, PCR, DNA sequencingBackground
Anaplasmosis, caused by Anaplasma phagocytophilum
and A. platys, and ehrlichiosis, caused by Ehrlichia canis, E.
chaffeensis, E. ewingii, E. muris and the “Panola Mountain
Ehrlichia”, are emerging infectious diseases affecting dogs
and human patients in North America and other parts of
the world [1-3]. Canine vector borne diseases (CVBDs), in-
cluding co-infections with more than one CVBD pathogen,
are common in dogs, particularly those with frequent or
constant vector exposure to varied tick species [4-6].
Among various animal species, including humans, Ana-
plasma and Ehrlichia spp. can induce acute, self-limiting or
fatal infections, while persistent non-clinical infections
often occur in dogs [7-9]. Following tick transmission, dogs* Correspondence: ed_breitschwerdt@ncsu.edu
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article, unless otherwise stated.can remain infected with A. phagocytophilum, A. platys, E.
canis, E. chaffeensis, and E. ewingii for months to years,
prior to immunological or therapeutic elimination of the in-
fection or the development of chronic debilitating disease
manifestations [7-9]. Dogs are natural hosts for A. platys, E.
canis and potentially E. ewingii, but are considered oppor-
tunistic hosts for other Anaplasma and Ehrlichia spp. [6,7].
Persistent E. chaffeensis [10,11] and E. canis [12,13] human
infections have been suspected previously. Recently, A.
platys DNA was PCR amplified from blood samples
collected from a veterinarian one month apart [14]. With
the advent of PCR testing, reports of long-term Anaplasma
and Ehrlichia human blood borne infections may become
more common.
The data in this manuscript was generated after a
physician requested to be entered into a Bartonella sp.
research study. At time points spanning a six-month
period, blood, buffy coat and inoculated cell cultures
from members of the household, tested by PCR andentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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Ehrlichia species. Anaplasma platys, E. chaffeensis, and
E. ewingii DNA was amplified and sequenced from the
dog, the physician and her daughter’s blood, but not
from two other household members.Methods
Patients and clinical presentation
In September 2011, a 57-year-old-female physician re-
quested to be entered into an IRB approved research study
(North Carolina State University, 164-08-05), investigating
the prevalence of Bartonella sp. bacteremia in various
patient populations. In 2008, the woman had developed
intermittent subcutaneous edema and mildly increased
liver enzyme activities. Her 16-year-old daughter, adopted
from China at 6 months of age, had been healthy until
2008, after which she developed upper body muscle pain
requiring treatment by a physical therapist. Between 2008
and 2011, both mother and daughter were examined by
several specialist physicians; neither had symptoms or
hematological abnormalities (thrombocytopenia) consist-
ent with anaplasmosis or ehrlichiosis; and both were HIV
negative.
In 2008 the family purchased a 15-week-old male Papillon
from a Chicago pet store. The puppy originated from a
Missouri breeding facility, a region endemic for tick borne
E. chaffeensis and E. ewingii. Due to an acute illness, the
puppy was hospitalized hours after purchase; pneumonia
was diagnosed radiographically and an extended hospitali-
zation period was required to effectively treat the pneu-
monia. Subsequently, aggressive behavior was observed,
resulting in occasional bites of the mother and daughter
but not the other household members. In 2012, the dog
was diagnosed with microvascular dysplasia, a congenital,
developmental abnormality common in small breed dogs,
that can contribute to hepatic dysfunction and behavioral
abnormalities, potentially explaining the tendency for the
dog to bite.Bartonella alpha proteobacteria (BAPGM) enrichment
blood culture/PCR
In accordance with a prior study [15], three sample sets
were collected within a 7-day period to enhance detection
of Bartonella spp. DNA using the BAPGM platform.
Using blood aseptically collected on Monday, Wednesday
and Friday (mother in September 2011, December 2011
and January 2012), (daughter in January and February
2012) and (dog in December 2011 and January 2012),
Bartonella spp. serology and BAPGM (Bartonella alpha
Proteobacteria growth medium) enrichment blood culture
testing for Bartonella spp. was performed, according to
previously published protocols [15,16].Buffy coat preparation
After the initial PCR amplification of E. chaffeensis DNA
from the mother’s blood in September 2011, aseptically
obtained ethylenediaminetetraacetic acid (EDTA)-anti-
coagulated whole blood was processed in two formats
(whole blood and buffy coat cells) in an effort to increase
Ehrlichia sp. PCR sensitivity. Blood samples (mother,
January, February and March) and (daughter, father and
grandmother, March only) were sent concurrently to the
NCSU-IPRL and UTMB for parallel tissue culture isola-
tion attempts.
Anaplasma/ehrlichia conventional PCR assays
Genomic DNA was extracted using either the QIAsymph-
ony SP (Qiagen, Valencia, CA) or the DNeasy Blood &
Tissue Kit (Qiagen, Valencia, CA) as per manufacturer
recommendations. Each DNA extraction process included
several negative control non-infected blood samples. To
avoid DNA contamination of samples, DNA extraction
and PCR sample preparation were performed in a room
separate from the PCR amplification and gel analysis
rooms, with a unidirectional work flow. Previously de-
scribed Anaplasma and Ehrlichia 16S rRNA gene conven-
tional PCR (cPCR) assays were used to test whole blood,
buffy coat and cell culture supernatant fractions prepared
from the mother, father, daughter, grandmother and dog
[17,18]. Amplifications were performed in a Mastercycler
EPgradient® aluminum block thermocycler (Eppendorf,
North America). GEPs and GEPr and GEPs and GEP1060r
primers were used respectively, to amplify 420 and 973bp
segments of the 16S rRNA gene [17] using Ehrlichia canis
DNA as a positive control. Subsequently, newly intro-
duced or derived (sodb) PCR assays were used by a
blinded IPRL researcher to target the A. platys p44 gene,
E. chaffeensis and E. ewingii p28 genes, and Ehrlichia spp.
sodb gene in blood and cell culture supernatants. Primers
and cPCR conditions are provided in Table 1. Amplicons
were assessed by electrophoresis of 8 μl of each product in
2% agarose gels containing ethidium bromide. DNA
extraction and PCR negative controls remained negative
throughout the study.
DNA sequencing
Amplicons were sequenced directly or cloned into plas-
mid pGEM-T Easy Vector System Promega® (Madison,
WI) by GENEWIZ Inc. (Research Triangle Park, NC).
Sequences were aligned and compared with GenBank
sequences using AlignX software (Vector NTI Suite 6.0,
InforMax, Inc.).
Serologic testing
After amplification of E. chaffeensis DNA from the
mother’s blood, her physician requested E. chaffeensis
serology from a commercial laboratory (Quest Diagnostics,
Table 1 Conventional PCR primer sequences and thermocycler conditions for assays used in this study
Target gene Size in base
pairs (bp)
Primers names and sequence, reaction mix and run conditions
Ehrlichia or Anaplasma
16S rRNA
420 bp GEPs 5’ CTG GCG GCA AGC YTA ACA CAT GCA AGT CGA ACG GA 3’
GEPr 5’ CTT CTT CTR TRG GTA CCG TCA TTA TCT TCC CYA YTG 3’
For 25 μL mix: 12.5 μL MyTaq HS mix (Bioline), 0.2 μL 100 μM each primer (IDT® DNA Technology), 7.3 μl
molecular grade water, + 5 μl template DNA. Denaturation 2 min @95°C, then 55 cycles 15 sec @94°C,
annealing 10 sec @64°C, extension 15 sec @72°C, final extension 30 sec @72°C.
Ehrlichia or Anaplasma
16S rRNA
973 bp GEPs 5’ CTG GCG GCA AGC YTA ACA CAT GCA AGT CGA ACG GA 3’
LongGEP1060r 5’CTG TGT RAG GTC CAG CCG AAC TGM SYC 3’
As above except annealing and extension times extended to 25 and 30 sec
Ehrlichia spp. sodb 300 bp sodbF 5’- TTT AAT AAT GCT GGT CAA GTA TGG AAT CAT
sodbR 5’- AAG CGT GTT CCC ATA CAT CCA TAG
For 50 μl mix: 24 μl MyTaq HS Mix (2X) (Bioline), 1 μl 50 uM each primer (Sigma-Aldrich), 4 μl molecular
grade water + 20 μl template DNA. Single hot start cycle 3 min @95°C, then 55 cycles denaturation
10 sec @94°C, annealing 15 sec @58°C, extension 15 sec @72°C, then a single cycle 30 sec @72°C.
E.chaffeensis p28 590 bp EchP28F 5’- GAC CCA ACA GGT AGT GGT ATT AAC GG
EchP28R 5’- CTG GGC TTA TAG AGT AGC TTA AAC CTA AC
For 25 μL mix: 12.5 μl MyTaq HS Mix (2X) (Bioline), 0.25 μl 50 uM each primer (Sigma-Aldrich), 7 μl
molecular grade water + 5 μl template DNA. Single hot start cycle 3 min @95°C, then 55 cycles
denaturation 15 sec @94°C, annealing 15 sec @58°C, extension 30 sec @72°C, then a single cycle 30 sec
@72°C.
E. ewingii p28 215 bp EEM2F (Ref 32) 5′-GGA GCT AAA ATA GAA GAT AAT C
EEM1R 5′-GTG CCA AAA GGT AAT ACA T
For 25 μl mix: 12.5 μl of MyTaq HS Mix (2X) (Bioline), 0.25 μl 50 μM each primer (Sigma-Aldrich), 2 μl
molecular grade water + 10 μl template DNA. Single hot start cycle 3 min @95°C, then 55 cycles
denaturation at 15 sec @94°C, annealing 15 sec @56°C, extension 30 sec @72°C, then a single cycle 1 min
@72°C.
A. platys p44 520 bp Apl_p44F3 5’- GCT AAG TGG AGC GGT GGC GAT GA CAG
Apl_p44R3 5’- CGA TCT CCG CCG CTT TCG TAT TCT TC
For 25 μL mix: 12.5 μl MyTaq HS Mix (2X) (Bioline), 0.3 μl 50 uM each primer (Sigma-Aldrich), 2 μl
molecular grade water + 10 μl template DNA. Single hot start cycle 3 min @95°C, then 55 cycles
denaturation 15 sec @94°C, annealing 10 sec @70°C, and extension 30 sec @72°C, then a single cycle
1 min @72°C.
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logical testing was performed at the Rickettsial Disease
Laboratory, UTMB. Serum specimens from all family
members from multiple collection dates were serially
diluted (twofold) from 1:64 to 1:2048 and tested for E.
chaffeensis IgG class antibodies by ImmunoFluorescent
assay (IFA) with Alexa Fluor 488 goat-anti-human second-
ary antibody (dilution 1:1000). An IFA titer of 1:64 or
higher was considered positive. E. chaffeensis Western im-
munoblot was performed by SDS-PAGE using NUPAGE
NoVEX 4-12% polyacrylamide gels (Invitrogen, Carlsbad,
CA). Separated proteins transferred to nitrocellulose mem-
brane using a Trans-Blot SD Semi-Dry Electrophoretic
Transfer Cell (Bio-Rad Laboratories, Hercules, CA) were
blocked overnight with 5% nonfat dry milk (Bio-Rad) in
1X Tris-buffered saline (TBS) before incubation with
serum samples diluted (1:100) in 5% nonfat dry milk in 1X
TBS overnight at room temperature. Blots were washed
thoroughly then incubated with alkaline phosphatase
labeled anti-human IgG (γ chain-specific) secondary anti-
bodies and color reactions developed with BCIP/NBT
phosphatase substrate (KPL, Inc. Gaithersburg, MD).Serum from the dog was tested for Ehrlichia antibodies by
IFA in the IPRL, using antigens derived from canine
monocytic DH82 cultures infected with E. canis and E.
chaffeensis and for Anaplasma or Ehrlichia antibodies
using the Snap® 4Dx®, (IDEXX Laboratories Inc., West-
brook, Maine) [19,20].Cell culture isolation
Parallel isolation attempts were made using white blood
cell pellets (WBC) into various cell lines at NCSU-IPRL
and UTMB. EDTA anti-coagulated whole blood from
each individual was lysed with either ACK lysis buffer
or hypotonic saline and centrifuged at UTMB or centri-
fuged in two stages at IPRL to prepare WBC pellets
which were suspended in medium and dispersed into
25 cm2 flasks containing DH82 and IES6 tick cells
(IPRL) or DH82, RF/6A, Vero, HEL299 and C6/36 cells
(UTMB) and incubated at 37°C in 5% CO2. Negative
control flasks were maintained in parallel. Cytology
(Diff Quik or Gimenez staining) and PCR were sequen-
tially performed.
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Exposure history
The family resided in suburban Chicago. There were no
forested areas that might contain tick-infested deer for at
least 1 mile in any direction. The mother did not recall
any tick infestations in the home before or after purchas-
ing the puppy and no family member reported a history of
tick attachment. Occasional raccoon, skunk, opossum,
coyote and other small mammals and birds were seen in
the neighborhood. The mother and daughter were the pri-
mary caregivers for the dog and the only family members
to have experienced consistent dog contact and occasional
bites.Bartonella serology and enrichment culture/PCR
Based upon sequential testing, Bartonella spp. antibodies
were not detected in the mother, daughter or dog’s serum
specimens, and at all testing time points, BAPGM enrich-
ment blood culture platform specimens (4 PCRs/sample/
date of collection) were Bartonella sp. PCR negative.
Thus, there was no serological or PCR evidence to sup-
port Bartonella spp. exposure or infection.Anaplasma/Ehrlichia conventional 16S rRNA PCR and
sequencing
Using 16S GEP primers that amplify both Anaplasma and
Ehrlichia species, Ehrlichia chaffeensis 16S rDNA was cPCR
amplified and sequenced from one of three September
2011 blood specimens (Table 2). The 16S rDNA sequence
shared 99.7% (359/360 base pair) similarity with E. chaffeensis
strain Arkansas CP000236 (Table 3). Based upon this
E. chaffeensis result, additional blood samples from the
mother, dog, daughter, father and maternal grandmother
were submitted for testing in the IPRL on five, four, three,
two and one occasion, respectively between September
2011 and March 2012.Table 2 Summary of conventional PCR amplification and DNA
fractions and DH82, RF/6A or IES6 cell cultures tested betwee
Date Mother Dog
Ech Eew Apl Ech Eew Apl Ec
09/2011 +# - - NT NT NT NT
12/2011 +# +* +* +# - - -
01/2012 +# +# +#* +# - +#* -
02/2012 +# +# - - +# +* -
03/2012 +* - - - - - +*
06/2012** - - - - - - -
Sample source or sources are designated for each testing time point.
Ech = Ehrlichia chaffeensis, Eew = Ehrlichia ewingii, Apl = Anaplasma platys, Ec = Ehrlich
All + results confirmed by DNA sequencing.
# = amplicon obtained from blood, serum or buffy coat fraction.
* = amplicon obtained from DH82, RF/6A or IES6 cell cultures.
NT = not tested.
** = post doxycycline treatment.Beginning with the mother’s December 2011 specimens,
DNA was independently extracted from whole blood and
WBC fractions from each family member in an effort
to enhance cPCR sensitivity. By sequential testing, E.
chaffeensis and E. ewingii 16S rDNA (99.7% similarity with
NR044747) ehrlichiemia was documented in the dog,
daughter and mother (Table 2). Also, at various time
points, A. platys 16S rDNA (749/750 bp, 99.9% similarity
to M82801) was amplified and sequenced from the dog
and mother’s blood. Amplified Anaplasma and Ehrlichia
DNA sequences shared between the dog, daughter and
mother were identical.Anaplasma/ehrlichia p28, p44 and sodb gene amplification
and DNA sequencing
To confirm the 16S rDNA PCR results, other Anaplasma
and Ehrlichia spp. genes were targeted, using freshly
extracted, stored, whole blood and WBC preparations.
The initial A. platys, E. chaffeensis and E. ewingii DNA
amplification results were confirmed by cPCR amplification
and DNA sequencing of the p44, p28, and sodb genes
(Table 3).Serology
When tested by a commercial laboratory in February
2012, the mother was reportedly E. chaffeensis seroreactive
(IgM < 1:40, IgG 1: 160); however, at UTMB, five sera col-
lected between September 2011 and March 2012 (mother)
and February and March (daughter) were not E. chaffeen-
sis seroreactive at a 1:64 dilution by IFA testing. Western
immunoblotting also did not identify Ehrlichia spp. anti-
bodies. When tested by the IPRL in January 2012, the dog
was not E. canis, Babesia canis, Babesia gibsoni, Barto-
nella henselae, Bartonella vinsonii subsp. berkhoffii, Leish-
mania infantum, or Rickettsia rickettsii IFA seroreactive
and was also ELISA negative for Dirofilaria immitissequencing results from whole blood, serum, WBC
n September 2011 and June 2012
Daughter Father/Grandmother
Ech Eew Apl Ec Ech Eew Apl Ec
NT NT NT NT NT NT NT NT
NT NT NT NT NT NT NT NT
- +# - - NT NT NT NT
- - +* - - - - -
+* - +* - - - - -
- - - - NT NT NT NT
ia canis.
Table 3 Confirmation of conventional PCR amplification
results by DNA sequencing of Ehrlichia and Anaplasma
gene targets derived from blood or WBC samples from
the mother, dog and daughter
Gene targeta Mother Daughter Dog
Ech Eew Apl Ech Eew Apl Ech Eew Apl
GEP 16S 99.7 99.7 99.9 no 99.7 no 99.7 99.7 99.9
sodB 100 99.2 NA no 100 NA 100 no NA
P28 96.6 100 NA no 100 NA 96.6 no NA
P44 NA NA 99.6 NA NA no NA NA 99.6
Based upon DNA sequence similarities, specimens from the dog and both
family members contained the same genotypes.
Ech = Ehrlichia chaffeensis.
Eew = E. ewingii.
Apl = Anaplasma platys.
NA = not an applicable gene target for the particular Anaplasma or
Ehrlichia species.
aNumbers represent % sequence identity to the following GenBank reference
sequences: A. platys 16S M82801 from a dog, A. platys p44 GQ868750.1 from a
Venezuela dog strain, E. chaffeensis 16S CP000236, complete genome of an
Arkansas human strain, E. chaffeensis sodB CP000236, E. chaffeensis p28 human
strains V8 (AF393394.1) and V4 (AF393390.1), E. ewingii 16S Accession
NR_044747 from an Oklahoma dog strain, E. ewingii sodB (GenBank KC778986)
from a naturally-infected dog procured through our diagnostic laboratory and
validated by other E. ewingii gene targets, and E. ewingii p28 AF287961.1 from
a dog strain and AF287962.1, AF287963.1 and AF287966.1 from human strains.
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peptide, and Ehrlichia spp. antibodies.Cell culture isolation
Organism isolation efforts at both NCSU and UTMB
generated Diff Quik or Gimenez staining indications of
intracellular bacteria or morulae, but did not result in
successful isolation or evidence of organism amplification
during 8–10 weeks in culture. Structures consistent with
morulae were observed in the dog, daughter and mother’s
inoculated cell cultures, but not in the father, grandmother
or un-inoculated control cell cultures. Anaplasma/Ehrli-
chia GEP 16S cPCR amplified E. ewingii and A. platys
from the dog, daughter and mother’s IPRL DH82 cultures.
E. chaffeensis DNA (16S rRNA, sodb, and p28) was ampli-
fied from daughter and mother’s UTMB RF/6A cultures.
The dog and mother’s E. chaffeensis 16S rRNA, sodb
sequences and A. platys p44 sequences from cell culture
were 100% identical to sequences previously amplifed
from blood, serum or WBC specimens. The dog’s March
2012 WBC inoculated DH82 (pid 8) and IES6 (pid 23) cell
cultures yielded 16S rRNA and sodb E. canis DNA.Treatment
In May 2012, the mother was treated with doxycycline
100 mg PO BID for 15 days and the dog was treated
with doxycycline 5 mg/kg every 12 hours for 5 weeks.
When retested in June 2012, blood and tissue culture
cPCR results were negative and morulae-like structures
were not visualized. The daughter was not treated.Discussion and conclusions
This study provided PCR amplification and sequencing
evidence supporting the persistence of A. platys, E. chaf-
feensis and E. ewingii DNA in the blood of a dog and
two family members. Specifically, during the six month
study period, E. chaffeensis, E. ewingii, and A. platys
DNA was amplified and sequenced from the mother’s
blood and/or cell culture supernatant specimens at 5, 3,
and 2 time points, respectively. Anaplasma and Ehrlichia
gene targets not routinely assayed in our laboratory con-
firmed the initial identification of pathogen DNA in all
three family members. Furthermore, the partial gene se-
quences amplified between family members were identi-
cal, suggesting they were infected with the same pathogen
genotypes. Despite repeated molecular documentation of
these bacteria, Ehrlichia spp. IFA antibody titers and
Western immunobloting were negative at UTMB and the
dog was not Anaplasma or Ehrlichia seroreactive at
NCSU-IPRL. As A. platys and E. ewingii have not been
successfully cultivated in cell culture, IFA serological
assays were not available for testing purposes. Whether
Anaplasma and Ehrlichia spp. co-infection altered the ex-
pected humoral immune response, whether assay antigens
were not well matched with the infecting genotypes or
whether anergy played a role in seronegativity remains un-
known. Similar comparative correlations between canine
and human vector-borne infections can be found in the
literature. Persistent infections, spanning months to years,
with A. platys, E. chaffeensis and E. ewingii, have been fre-
quently reported in dogs [6,7,18,21]. In contrast, there is
limited evidence supporting persistent human E. chaffeen-
sis infections [10,11]. Based upon challenge studies, dogs
can be experimentally re-infected with a homologous or
heterologous E. canis isolate, thus infection does not infer
protective immunity in dogs [22]. Re-infection with E.
chaffeensis has also been reported in a liver transplant pa-
tient [23]. In conjunction with improved diagnostic testing
modalities, co-infections of vector-borne diseases have
been reported in dogs and in human patients. As dogs are
more frequently exposed to ticks than their human coun-
terparts, co-infections are more often reported in dogs
[5-7,19] however, among other examples, E. chaffeensis
and Rickettsia rickettsii co-infection was reported in a 44-
year-old man [24]. Experimentally, A. platys and E. canis
co-infections in dogs [18], influenced the patterns and
severity of hematologic and serologic findings.
To confirm and validate the initial, unexpected 16S
rDNA PCR results from the mother and subsequently the
daughter and dog, other gene targets were amplified and
sequenced, isolation was attempted in two laboratories,
and two investigators tested samples independently and at
different time points. Because microbial-specific genes
were targeted, the same PCR assays are applicable for test-
ing human and veterinary patient populations and vectors
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False negative results occur when testing samples with
low template concentrations and selective amplification
of the predominant organism can occur in patients co-
infected with genetically similar organisms. By comparing
PCR results from different sample sources (blood, serum,
buffy coat, and tissue culture extracts), the assays used in
this study may not have been sensitive enough to consist-
ently detect these bacteria within blood specimens col-
lected during the same week (data not shown), illustrating
the need to enhance the sensitivity of Anaplasma and
Ehrlichia PCR, particularly when patient samples contain
DNA sequences of genetically related organisms. DNA
carryover or amplicon contamination within a laboratory
may result in false positives [25,26]. Importantly, through-
out this study, all DNA extraction and PCR-negative con-
trols remained negative. Furthermore, PCR testing of blood,
serum, WBC, and tissue culture extracts from the father or
maternal grandmother did not identify Anaplasma and
Ehrlichia sp. DNA, and both the dog and mother became
PCR negative after treatment with doxycycline, a finding
that supports infection with viable organisms.
Nearly two decades ago investigators in Venezuela de-
scribed inclusions in human platelets, a subset of which
were ultrastructurally consistent with A. platys [27,28].
Until recently [14], no subsequent report of human A.
platys infection was published in the English literature.
There is substantial epidemiological support for Rhipice-
phalus sanguineus (the brown dog or kennel tick) as the
vector and the dog as the primary reservoir host for A.
platys and E. canis [20]. As the puppy in this study origi-
nated from a kennel in Missouri, exposure to R. sanguineus
seemed more likely than exposure to A. americanum,
which is a field tick that will feed on numerous animal
species [29]. Although vector competence has not been
proven, E. chaffeensis DNA was amplified from 56% of R.
sanguineus obtained from dogs and puppies housed in a
kennel in Cameroon, a country where both canine and
human infection with E. chaffeensis has been previously
reported [30]. In contrast, recent efforts to experimentally
transmit E. ewingii by R. sanguineus were not successful
[31]. The source of A. platys, E. chaffeensis and E. ewingii
infection in the pet and the family members and E. canis in
the dog remains unknown; however, this puppy originated
from a kennel in a highly endemic state for tick transmis-
sion of E. chaffeensis and E. ewingii by A. americanum
[1,29] and A. platys and E. canis are transmitted by a tick
(R. sanguineus) that infests dogs in kennels.
In summary, A. platys and Ehrlichia spp. DNA was
documented in an unusual familial cluster involving a dog
and two family members. Future studies should determine
whether repeated documentation of DNA of these organ-
isms reflects ongoing infection and whether there are
medical consequences associated with the persistence ofDNA of these organisms. To guide testing and treatment
decisions, sequential PCR testing of blood, WBC or cell
culture-enhanced samples may increase DNA-detection
sensitivity.
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